Director Donohue Lilly files initial Form 3 at NATIONAL HEALTH (NHI)

Rhea-AI Filing Summary

NATIONAL HEALTH INVESTORS INC director Donohue Lilly has filed a Form 3, which is an initial statement of beneficial ownership. The filing lists Donohue Lilly as a director of the company and does not report any insider buy, sell, acquire, or dispose transactions in this data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 02/27/2026 - 02:18 PM Learn about SEC filing dates

FAQ

What does the Donohue Lilly Form 3 filing for NHI show?

The Form 3 for NATIONAL HEALTH INVESTORS INC lists Donohue Lilly as a director and serves as an initial statement of beneficial ownership. In this data, it does not show any insider share purchases, sales, or other transactions.

Does the NHI Form 3 for Donohue Lilly report any stock trades?

No, this Form 3 data for NATIONAL HEALTH INVESTORS INC shows no insider stock trades for Donohue Lilly. The transaction summary indicates zero buy, sell, acquire, dispose, or other transactions and a neutral net share change.

What is Donohue Lilly’s role at NATIONAL HEALTH INVESTORS INC (NHI)?

According to the Form 3 data, Donohue Lilly is a director of NATIONAL HEALTH INVESTORS INC. The filing flags Donohue Lilly as a director and not as an officer or ten percent owner based on the provided role indicators.

Why is a Form 3 filed for Donohue Lilly at NHI?

Form 3 is filed to provide an initial statement of beneficial ownership for insiders. For NATIONAL HEALTH INVESTORS INC, Donohue Lilly’s Form 3 establishes director status and insider reporting, even though no specific stock transactions appear in this dataset.

Does the Donohue Lilly Form 3 for NHI include any explanatory footnotes?

The Form 3 data includes a footnotes section, but in this instance it contains no substantive text. There are no additional explanations about ownership structure, voting power, or related entities in the provided information.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Donohue Lilly

(Last) (First) (Middle)

222 ROBERT ROSE DR

(Street)

MURFREESBORO TN 37129

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/17/2026

3. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Kimberly V. Ouimet, by limited power of attorney	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.